Privacy Guidance, HCFA Info Tech Reform High Among Thompson's Priorities
This article was originally published in The Gray Sheet
HHS will develop a guidance to clarify problems identified with the "minimum necessary" provision of the department's final medical privacy rule, according to Secretary Tommy Thompson.
You may also be interested in...
A Phase III trial testing the antibody-drug conjugate sacituzumab govitecan was stopped early for efficacy, boding well for the BLA pending at the US FDA.
Deal Snapshot: Six companies seek to collect convalescent plasma from COVID-19 survivors to quickly develop hyperimmune immunoglobulin therapy for serious complications of the virus.
Pharmaceutical companies struggling to keep up with coronavirus-related supply chain havoc asked to keep the US regulator informed as situation unfolds.